...
首页> 外文期刊>Journal of neurointerventional surgery >Implementation of a patient selection protocol for intra-arterial therapy increases treatment rates in patients with acute ischemic stroke.
【24h】

Implementation of a patient selection protocol for intra-arterial therapy increases treatment rates in patients with acute ischemic stroke.

机译:实施患者选择方案进行动脉内治疗可提高急性缺血性中风患者的治疗率。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Strategies for patient selection for intra-arterial therapy (IAT) in acute ischemic stroke (AIS) are highly variable. The degree of protocol adoption and treatment rates associated with implementation of a service-wide patient selection IAT protocol were assessed.All patients with AIS prospectively recorded in our stroke database from January 2007 to June 2009 were reviewed. The IAT patient selection protocol was implemented in March 2008. Patients were defined as likely to benefit (LTB) from IAT if they had brain imaging completed within 6 h from last known well time, NIH Stroke Scale score ≥ 8, infarct volume ≤ 100 ml and evidence of proximal artery occlusion.Of 1348 subjects identified, 118 (8.7%) met the criteria for LTB and 62 (52%) underwent IAT. There was a significant increase in rates of IAT among LTB patients after protocol implementation (61% vs 40%, p<0.02). In LTB patients, factors associated with IAT were stroke duration (OR 0.78, 95% CI 0.6 to 0.9 per hour), arrival within later calendar months during study period (OR 1.1, 95% CI 1.02 to 1.2 per month), intravenous tissue plasminogen activator (OR 0.6, 95% CI 0.4 to 0.9) and age (OR 0.98, 95% CI 0.95 to 1.02 per year). After multivariable adjustment, only stroke duration (OR 0.65, 95% CI 0.5 to 0.8 per hour) remained an independent predictor of IAT.Most patients with AIS did not meet our criteria for LTB and only 52% of those defined as LTB received IAT. Protocol adoption increased the use of IAT over time; however, further exploration of factors associated with the reasons for non-treatment and the impact of IAT on outcomes is necessary.
机译:急性缺血性卒中(AIS)的动脉内治疗(IAT)的患者选择策略差异很大。评估了与实施全服务患者选择IAT方案相关的方案采用程度和治疗率。回顾性分析了2007年1月至2009年6月在我们的卒中数据库中记录的所有AIS患者。 IAT患者选择方案于2008年3月实施。患者被定义为如果在最近一次已知的随访时间后6小时内完成了脑成像,NIH中风评分≥8,梗死体积≤100 ml,则可能从IAT获益(LTB)在确定的1348名受试者中,有118名(8.7%)符合LTB标准,而62名(52%)接受了IAT。实施方案后,LTB患者的IAT发生率显着增加(61%vs 40%,p <0.02)。在LTB患者中,与IAT相关的因素包括卒中持续时间(OR 0.78,95%CI 0.6至0.9每小时),研究期间晚几个日历月内到达(OR 1.1,95%CI 1.02至1.2每月),静脉内组织纤溶酶原活化剂(OR 0.6,95%CI 0.4至0.9)和年龄(OR 0.98,95%CI 0.95至1.02每年)。经过多变量调整后,只有卒中持续时间(OR 0.65,95%CI 0.5至0.8每小时)仍然是IAT的独立预测因素。大多数AIS患者不符合我们的LTB标准,只有52%定义为LTB的患者接受了IAT。随着时间的推移,协议的采用增加了IAT的使用;但是,有必要进一步探讨与不治疗原因以及IAT对预后的影响有关的因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号